1. Home
  2. TSI vs PROF Comparison

TSI vs PROF Comparison

Compare TSI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TCW Strategic Income Fund Inc.

TSI

TCW Strategic Income Fund Inc.

HOLD

Current Price

$4.95

Market Cap

234.6M

Sector

Finance

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.34

Market Cap

230.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSI
PROF
Founded
1987
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.6M
230.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TSI
PROF
Price
$4.95
$7.34
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
106.8K
142.9K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
7.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,297,000.00
Revenue This Year
N/A
$64.23
Revenue Next Year
N/A
$113.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.94
52 Week Low
$4.48
$3.76
52 Week High
$4.87
$7.99

Technical Indicators

Market Signals
Indicator
TSI
PROF
Relative Strength Index (RSI) 56.05 57.66
Support Level $4.90 $7.22
Resistance Level $4.96 $7.95
Average True Range (ATR) 0.04 0.42
MACD 0.00 0.03
Stochastic Oscillator 80.95 65.14

Price Performance

Historical Comparison
TSI
PROF

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: